表紙
市場調查報告書

維他命D療法的全球市場 - 至2024年的預測:口服給藥,非口服給藥

Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 832935
出版日期 內容資訊 英文 113 Pages
訂單完成後即時交付
價格
Back to Top
維他命D療法的全球市場 - 至2024年的預測:口服給藥,非口服給藥 Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024
出版日期: 2019年04月29日內容資訊: 英文 113 Pages
簡介

維他命D療法市場預計將從2019年的19億美元,擴大到2024年的33億美元的規模。市場在2019年∼2024年間,預測將以年複合成長率 (CAGR) 11.6%的速度成長。

本報告提供全球維他命D療法市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 維他命D:市場概要
  • 北美 - 維他命D療法市場:各給藥途徑
  • 維他命D療法市場各地區概述

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 機會
    • 課題

第6章 疾病的進展的維他命D所扮演的角色

  • 癌症的預防、治療中維他命D所扮演的角色
  • 糖尿病的預防、治療中維他命D所扮演的角色
  • 心血管疾病的預防、治療中維他命D所扮演的角色

第7章 維他命D療法的全球市場:各給藥途徑

  • 簡介
  • 口服給藥
  • 非口服給藥

第8章 維他命D療法的全球市場:各購買模式

  • 簡介
  • 處方藥
  • OTC藥

第9章 維他命D療法的全球市場:各適應症

  • 簡介
  • 骨質疏鬆症
  • 佝僂病
  • 肌肉無力
  • 自體免疫疾病
  • 皮膚病
  • 其他

第10章 維他命D療法的全球市場:各年齡層

  • 簡介
  • 老人
  • 成人
  • 兒童

第11章 維他命D療法的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第12章 競爭情形

  • 概要
  • 市場排行榜分析
  • 主要策略
  • 競爭領導製圖

第13章 企業簡介

  • NOVARTIS AG
  • PFIZER INC
  • GLAXOSMITHKLINE PLC
  • MERCK & CO., INC.
  • ABBOTT
  • SANOFI
  • TORRENT PHARMACEUTICALS LTD.
  • SUN PHARMACEUTICAL INDUSTRIES LTD.
  • ALKEM LABORATORIES LTD.
  • CADILA HEALTHCARE LTD.

第14章 附錄

目錄
Product Code: PH 7060

"Vitamin D therapy market to register a CAGR of 11.6% from 2019 to 2024."

The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency, growing focus on healthy diets among consumers, and the presence of a large target patient population. Emerging economies with growing healthcare expenditures are also expected to provide opportunities for the growth of the market. On the other hand, the fortification of foods is likely to challenge market growth to a certain extent.

"Oral route of administration accounted for a significant share of the market, by route of administration, in 2018."

By route of administration, the vitamin D therapy market is segmented into oral and parenteral routes of administration. In 2018, the oral route of administration accounted for the largest market share. This segment is also expected to grow at the highest CAGR during the forecast period. This is mainly due to the ease of administration, better pharmacokinetic and pharmacodynamic activity, and a higher preference for the oral route.

"By purchasing pattern, prescription drugs held the largest share of the vitamin D therapy market in 2018."

On the basis of purchasing pattern, the vitamin D therapy market is segmented into OTC and prescription drugs. In 2018, the prescription drugs segment accounted for the largest share of the vitamin D therapy market. The large share of this segment can be attributed to the fact that vitamin D deficiency is mostly diagnosed by registered medical practitioners that provide prescriptions for appropriate medications.

"Asia Pacific dominated the vitamin D therapy market in 2018."

The Asia Pacific, which includes China, Japan, India, and the Rest of Asia Pacific, accounted for the largest share of the vitamin D therapy market. The large share of this market segment can be attributed to the increasing awareness about vitamin D deficiency and supportive government policies and programs for the implementation of vitamin D deficiency treatment plans, heavy air pollution, sedentary lifestyles, increasing incidence of vitamin D deficiency, atypical diets, decreasing sun exposure, and rising malnutrition levels.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35%
  • By Designation: C-level - 30%, Director-level - 20%, and Others - 50%
  • By Region: North America - 35%, Europe - 24%, Asia Pacific - 25%, and RoW - 16%

Research Coverage:

This report studies the vitamin D therapy market by route of administration, application, age group, purchasing pattern, and region. The report also analyzes factors such as drivers, opportunities, and challenges affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total vitamin D therapy market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on vitamin D offered by the top 10 players in the vitamin D therapy market. The report analyzes the market by route of administration, application, age group, purchasing pattern, and region
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various vitamin D supplements across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vitamin D therapy market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the vitamin D therapy market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 MARKETS COVERED
    • 1.2.2 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 SECONDARY DATA
    • 2.1.1 KEY DATA FROM SECONDARY SOURCES
  • 2.2 PRIMARY DATA
    • 2.2.1 KEY DATA FROM PRIMARY SOURCES
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
    • 2.3.2 TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 VITAMIN D: MARKET OVERVIEW
  • 4.2 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION (2019)
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE VITAMIN D THERAPY MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing awareness about vitamin d deficiency among consumers
      • 5.2.1.2 Presence of a large target patient population
    • 5.2.2 MARKET OPPORTUNITIES
      • 5.2.2.1 Growth opportunities in countries with a high prevalence of undernutrition
    • 5.2.3 MARKET CHALLENGES
      • 5.2.3.1 Fortified foods

6 ROLE OF VITAMIN D IN DISEASE PROGRESSION

  • 6.1 ROLE OF VITAMIN D IN THE PREVENTION AND TREATMENT OF CANCER
  • 6.2 ROLE OF VITAMIN D IN THE PREVENTION AND TREATMENT OF DIABETES
  • 6.3 ROLE OF VITAMIN D IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES

7 VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION

  • 7.1 INTRODUCTION
  • 7.2 ORAL ROUTE OF ADMINISTRATION
    • 7.2.1 ORAL ROUTE OF ADMINISTRATION LIKELY TO DOMINATE THE VITAMIN D THERAPY MARKET DUE TO HIGH PATIENT COMPLIANCE
  • 7.3 PARENTERAL ROUTE OF ADMINISTRATION
    • 7.3.1 USE OF PARENTERALS IS MOSTLY RESERVED FOR HYPOVITAMINOSIS D

8 VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN

  • 8.1 INTRODUCTION
  • 8.2 PRESCRIPTION DRUGS
    • 8.2.1 GROWING HYPOVITAMINOSIS D PREVALENCE IS EXPECTED TO DRIVE THE PRESCRIPTION DRUGS MARKET
  • 8.3 OVER-THE-COUNTER DRUGS
    • 8.3.1 EASE OF PURCHASE LEADS TO PEOPLE OPTING FOR OTC

9 VITAMIN D THERAPY MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 OSTEOPOROSIS
    • 9.2.1 FRACTURES AND BROKEN BONES LEADING TO RISE IN VITAMIN D THERAPY MARKET
  • 9.3 RICKETS
    • 9.3.1 UPDATED GUIDELINES ON DAILY DIETARY INTAKE OF VITAMIN D LIKELY TO LOWER INCIDENCE OF RICKETS
  • 9.4 MUSCLE WEAKNESS
    • 9.4.1 EVIDENCE INDICATES IMPACT OF VITAMIN D ON ATHLETE AND INJURY PROFILES
  • 9.5 AUTOIMMUNE DISORDERS
    • 9.5.1 RESEARCH IS REQUIRED TO UNDERSTAND THE ROLE OF VITAMIN D IN AUTOIMMUNE DISORDERS
  • 9.6 SKIN DISEASES
    • 9.6.1 IMMUNOMODULATORY ACTIVITY OF VITAMIN D LIKELY TO INCREASE THE MARKET FOR PSORIASIS
  • 9.7 OTHER APPLICATIONS

10 VITAMIN D THERAPY MARKET, BY AGE GROUP

  • 10.1 INTRODUCTION
  • 10.2 SENIOR ADULTS
    • 10.2.1 INCREASING INCIDENCE OF OSTEOPOROSIS AMONG SENIOR ADULTS HAS DRIVEN DEMAND FOR VITAMIN D
  • 10.3 ADULTS
    • 10.3.1 SEDENTARY LIFESTYLES ARE LEADING TO HYPOVITAMINOSIS D AMONG ADULTS
  • 10.4 CHILDREN
    • 10.4.1 HIGH PREVALENCE OF RICKETS AMONG CHILDREN IS DRIVING MARKET GROWTH

11 VITAMIN D THERAPY MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 US
      • 11.2.1.1 US to dominate the North American vitamin D therapy market
    • 11.2.2 CANADA
      • 11.2.2.1 Limited endogenous synthesis and limited dietary sources are the major factors responsible for vitamin D deficiency in the Canadian population
  • 11.3 EUROPE
    • 11.3.1 UK
      • 11.3.1.1 Vitamin D deficiency is prevalent among all age groups in the UK
    • 11.3.2 GERMANY
      • 11.3.2.1 High prevalence of osteoporosis is expected to be the key factor driving market growth in Germany
    • 11.3.3 FRANCE
      • 11.3.3.1 Vitamin D levels are declining in France
    • 11.3.4 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 CHINA
      • 11.4.1.1 Heavy air pollution and sedentary lifestyles are driving market growth in China
    • 11.4.2 JAPAN
      • 11.4.2.1 Increasing incidence of vitamin D deficiency in Japan to drive market growth
    • 11.4.3 INDIA
      • 11.4.3.1 A large part of India's population is vitamin D-deficient
    • 11.4.4 REST OF ASIA PACIFIC
  • 11.5 REST OF THE WORLD

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 MARKET RANKING ANALYSIS, 2018
  • 12.3 KEY STRATEGIES
    • 12.3.1 ACQUISITIONS AND COLLABORATIONS, 2015-2018
  • 12.4 COMPETITIVE LEADERSHIP MAPPING (2018)
    • 12.4.1 VISIONARY LEADERS
    • 12.4.2 INNOVATORS
    • 12.4.3 DYNAMIC DIFFERENTIATORS
    • 12.4.4 EMERGING COMPANIES

13 COMPANY PROFILES

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 13.1 NOVARTIS AG
  • 13.2 PFIZER INC
  • 13.3 GLAXOSMITHKLINE PLC
  • 13.4 MERCK & CO., INC.
  • 13.5 ABBOTT
  • 13.6 SANOFI
  • 13.7 TORRENT PHARMACEUTICALS LTD.
  • 13.8 SUN PHARMACEUTICAL INDUSTRIES LTD.
  • 13.9 ALKEM LABORATORIES LTD.
  • 13.10 CADILA HEALTHCARE LTD.

Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 INSIGHTS OF INDUSTRY EXPERTS
  • 14.2 DISCUSSION GUIDE
  • 14.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4 AVAILABLE CUSTOMIZATIONS
  • 14.5 RELATED REPORTS
  • 14.6 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 2: VITAMIN D THERAPY MARKET FOR ORAL ROUTE OF ADMINISTRATION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 3: VITAMIN D THERAPY MARKET FOR PARENTERAL ROUTE OF ADMINISTRATION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 4: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • TABLE 5: VITAMIN D THERAPY MARKET FOR PRESCRIPTION DRUGS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: VITAMIN D THERAPY MARKET FOR OTC DRUGS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 8: VITAMIN D THERAPY MARKET FOR OSTEOPOROSIS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: VITAMIN D THERAPY MARKET FOR RICKETS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 10: VITAMIN D THERAPY MARKET FOR MUSCLE WEAKNESS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: VITAMIN D THERAPY MARKET FOR AUTOIMMUNE DISORDERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: VITAMIN D THERAPY MARKET FOR SKIN DISEASES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: VITAMIN D THERAPY MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017-2024 (USD MILLION)
  • TABLE 15: VITAMIN D THERAPY MARKET FOR SENIOR ADULTS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: VITAMIN D THERAPY MARKET FOR ADULTS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: VITAMIN D THERAPY MARKET FOR CHILDREN, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: VITAMIN D THERAPY MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: NORTH AMERICA: VITAMIN D THERAPY MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 20: NORTH AMERICA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 21: NORTH AMERICA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • TABLE 22: NORTH AMERICA: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 23: NORTH AMERICA: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017-2024 (USD MILLION)
  • TABLE 24: US: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 25: US: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • TABLE 26: US: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 27: US: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017-2024 (USD MILLION)
  • TABLE 28: CANADA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 29: CANADA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • TABLE 30: CANADA: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 31: CANADA: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017-2024 (USD MILLION)
  • TABLE 32: EUROPE: VITAMIN D THERAPY MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 33: EUROPE: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 34: EUROPE: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • TABLE 35: EUROPE: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 36: EUROPE: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017-2024 (USD MILLION)
  • TABLE 37: UK: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 38: UK: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • TABLE 39: UK: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 40: UK: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017-2024 (USD MILLION)
  • TABLE 41: GERMANY: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 42: GERMANY: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • TABLE 43: GERMANY: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 44: GERMANY: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017-2024 (USD MILLION)
  • TABLE 45: FRANCE: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 46: FRANCE: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • TABLE 47: FRANCE: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 48: FRANCE: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017-2024 (USD MILLION)
  • TABLE 49: ROE: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 50: ROE: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • TABLE 51: ROE: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 52: ROE: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017-2024 (USD MILLION)
  • TABLE 53: APAC: VITAMIN D THERAPY MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 54: APAC: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 55: APAC: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • TABLE 56: APAC: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 57: APAC: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017-2024 (USD MILLION)
  • TABLE 58: CHINA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 59: CHINA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • TABLE 60: CHINA: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 61: CHINA: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017-2024 (USD MILLION)
  • TABLE 62: JAPAN: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 63: JAPAN: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • TABLE 64: JAPAN: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 65: JAPAN: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017-2024 (USD MILLION)
  • TABLE 66: INDIA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 67: INDIA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • TABLE 68: INDIA: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 69: INDIA: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017-2024 (USD MILLION)
  • TABLE 70: ROAPAC: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 71: ROAPAC: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • TABLE 72: ROAPAC: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 73: ROAPAC: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017-2024 (USD MILLION)
  • TABLE 74: ROW: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
  • TABLE 75: ROW: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • TABLE 76: ROW: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 77: ROW: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: VITAMIN D THERAPY MARKET: BOTTOM-UP APPROACH
  • FIGURE 4: VITAMIN D THERAPY MARKET: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 7: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: VITAMIN D THERAPY MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: VITAMIN D THERAPY MARKET, BY REGION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 11: GROWING AWARENESS ABOUT VITAMIN D DEFICIENCY AND LARGE PATIENT POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 12: ORAL ROUTE OF ADMINISTRATION TO DOMINATE THE NORTH AMERICAN VITAMIN D THERAPY MARKET IN 2019
  • FIGURE 13: ASIAN COUNTRIES TO REGISTER HIGH GROWTH RATES DURING THE FORECAST PERIOD
  • FIGURE 14: VITAMIN D THERAPY MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: NORTH AMERICA: VITAMIN D THERAPY MARKET SNAPSHOT
  • FIGURE 16: ASIA PACIFIC: VITAMIN D THERAPY MARKET SNAPSHOT
  • FIGURE 17: KEY DEVELOPMENTS IN THE VITAMIN D THERAPY MARKET FROM 2015 TO 2018
  • FIGURE 18: VITAMIN D THERAPY MARKET RANKING, BY KEY PLAYER, 2018
  • FIGURE 19: MNM DIVE-VENDOR COMPARISON MATRIX: VITAMIN D THERAPY MARKET
  • FIGURE 20: NOVARTIS AG: COMPANY SNAPSHOT (2018)
  • FIGURE 21: PFIZER INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 22: GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT (2018)
  • FIGURE 23: MERCK & CO., INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 24: ABBOTT: COMPANY SNAPSHOT (2018)
  • FIGURE 25: SANOFI: COMPANY SNAPSHOT
  • FIGURE 26: TORRENT: COMPANY SNAPSHOT (2018)
  • FIGURE 27: SUN PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT (2018)
  • FIGURE 28: ALKEM LABORATORIES LTD.: COMPANY SNAPSHOT (2018)
  • FIGURE 29: CADILA HEALTHCARE LTD.: COMPANY SNAPSHOT (2018)
Back to Top